ABVC BioPharma, Inc. Prepaid Expense and Other Assets, Current
ABVC BioPharma, Inc. (ABVC) had Prepaid Expense and Other Assets, Current of $151.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $151.56K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $250.02K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $346.62K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $447.28K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $151.56K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $250.02K 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $346.62K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $447.28K 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $195.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $96.36K 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $96.21K 10-Q/A · filed 2026-03-03 | |
| 2024-09-30 | $114.25K 10-Q/A · filed 2026-03-03 | $91.29K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $219.65K 10-Q · filed 2025-08-13 | $100.81K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $383.31K 10-Q · filed 2025-04-30 | $159.60K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $101.05K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $143.13K 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $148.02K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $347.85K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $150.24K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $287.18K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.30M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $631.32K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $528.35K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $815.92K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $817.89K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $631.72K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $172.19K 10-K · filed 2022-03-31 |